Robert Reznick
Rob Reznick is a partner in the firm’s Complex Litigation & Dispute Resolution Group, with a focus on the representation of pharmaceutical and other life sciences companies. He is Co-Chair of the Firm’s Life Sciences Practice.
This author's article(s)
- Antitrust Implications of the U.S. Supreme Court’s Decision in RJR Nabisco v. European CommunityDavid M. Goldstein and Robert Reznick, Orrick, June 2016
- District Court Follows Motorola Mobility to Apply FTAIA and Indirect Purchaser Doctrine to Dismiss U.S. Parent’s Price-Fixing Claims Based on Its Foreign Subsidiary’s PurchasesDavid M. Goldstein et al., Orrick, 2016
Download our brochure
© 2022 - Concurrences